Advertisement

Ads Placeholder
Loading...

Organigram Global Inc.

OGI•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.38
$0.04(2.99%)
U.S. Market opens in 0h 57m

Organigram Global Inc. (OGI) Stock Overview

Explore Organigram Global Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap188.1M
P/E Ratio14.30
EPS (TTM)$0.11
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$1.59
3 Months$1.34
1 Year Target$1.43

OGI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Organigram Global Inc. (OGI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.29, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.43.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.30 and a market capitalization of 188.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.99%
5-Day Change
5.34%
1-Month Change
0.73%
3-Month Change
-20.23%
6-Month Change
-26.60%
Year-to-Date (YTD) Change
-20.23%
1-Year Change
40.72%
3-Year Change
-45.24%
5-Year Change
-90.11%
All-Time (Max) Change
-95.58%

Contact Information

https://www.organigram.ca
15063841571
35 English Drive, Moncton, NB, E1E 3X3

Company Facts

10,930 Employees
IPO DateMay 21, 2019
CountryCA
Actively Trading

Frequently Asked Questions